ABSTRACT
Testicular germ cell cancer (TGCT) is the most common malignancy among young adult males, which has become important due to its increased incidence and mortality in the population worldwide. The etiology is multifactorial. Recent studies have shown some associations between the development of isolated TGCT and certain risk factors, such as exposure to endocrine disruptors, cryptorchidism, and family history of cancer, in order to identify the key pieces in carcinogenesis. Some of the most important findings in recent years is the association of different genes, such as c-KIT/KITLG, expression of the miR-371-373 cluster and protein expression as c-KIT and POU5F1 in the development of this neoplasia, and the identification of new molecular markers as TGFBR3 gene, identifying aberrant methylation patterns in promoter regions of several genes, expression of miR-1297 which regulates PTEN and protein expression as DMTR1. In the future, a multidisciplinary research strategy could provide valuable new insights into the etiology of TGCTs, which support clinical diagnosis of TGCT in the next years to increase survival in this kind of patients.
INTRODUCTION
Testicular germ cell tumor (TGCT; OMIM 273300) is the most common solid tumor in men and young adults between 15 and 45 years old and represents a major cause of death in this group of individuals (1) . Its incidence has been increasing worldwide in recent decades, probably due to increased exposure to etiological factors (2) , although this Figure (3) (4) . In 2012, a worldwide incidence was estimated with 55,226 new cases and 10,351 deaths. In Mexico, in the same year, 1,602 new cases and a total of 347 deaths from this disease were reported (5) . When comparing TGCT incidence rates in different populations, it was observed that rates were similar among Hispanic/Latino populations, specifically in Mexico, compared to the United States and Great Britain (6) . However, in Mexico the mortality rate is higher than in those countries, probably due to late diagnosis. Overall, the risk for the development of TGCT is higher in Caucasian populations than in African and Asian populations; however, the reasons for these differences in the incidence of TGCT among different ethnic groups are unknown (7) . Clinical and epidemiological studies suggest that both environmental and genetic factors play an important role in the origin and development of TGCT. In humans, early stages of development (embryonic, fetal and infant) are vulnerable to environmental effects. It has been proposed that intrauterine exposure to endocrine disruptors (EDs) could have different effects on fetal development and induces genital malformations in boys (8) (9) (10) . Although epidemiological studies have shown some controversy, it is proposed that the damage caused by EDs may depend on dosage, exposure time, developmental stage of each individual, maternal lifestyle, genetic factors and the genetic variability of susceptibility to the exposure to EDs (8, 11) . It has been observed that certain genes and miRNAs that have not been reported can be involved in the pathogenesis of TGCT. Moreover, it is documented that cryptorchidism or no testicular descent (CO; OMIM # 219050) is a risk factor for the development of TGCT. Patients with CO are 7 to 10 times more likely to develop TGCT than the general population, although this association is established, the mechanisms that lead to this disease are not yet known, but it is proposed that the TGCT is originated from a histological precursor called intratubular germ cell neoplasia unclassified (IGCNU), is now known as germ cell neoplasia in situ (GCNIS) (12) (13) (14) (15) . It has been documented in several studies the association of CO and the risk of developing malignancy in adulthood, proposing CO as a symptom of a future alteration with higher impact to cancer and reproductive level (16) (17) (18) (19) (20) . Undoubtedly, advances in knowledge of TGCT have led to improved strategies to optimize a timely diagnosis, so this review aims to describe some of the risk factors contributing to the pathophysiology of this cancer, such as environmental, genetics and epigenetics mechanisms.
TESTICULAR GERM CELL TUMOR
The TGCT is the most common solid testicular tumor. About 95 percent of them are TGCT, and the remaining 5 percent correspond to non-germ cell line tumors such as Sertoli cell tumors, Leydig cell tumors, or lymphomas. The TGCT occurs early in men, affecting one or both testicles. It is considered a heterogeneous genitourinary malignancy clinically asymptomatic in its early stages, which is commonly treated successfully, although a significant rate of morbidity and mortality has been reported (21) . The World Health Organization (WHO) has histologically classified TGCT into two groups: 1) the testicular germ cell tumors of seminoma type (sTGCT) representing about 55 percent of cases being reported, in most cases sensitive to treatment with radiation therapy and cisplatin-based chemotherapy; 2) the testicular germ cell tumor type nonseminoma (nsTGCT) representing about 45 percent of cases, in this group mixed tumors (tumors of the type nonseminoma with seminoma component) are included, such tumor usually does not respond to radiation therapy, but is sensitive to chemotherapy. The sTGCT represents a set of undifferentiated cells that resemble primordial germ cells (PGC) and can be classified into groups: 1) the classical or typical sTGCT representing about 95 percent of cases, originating from gonocytes or PGC with a predominance in young adult patients, and 2) spermatocytic sTGCT with a source in spermatocytes, occurs in adults 50 and older. The nsTGCT usually occurs in younger patients and brings together 2 cell lines: 1) tumors of embryonic lineage as embryonal carcinoma and teratoma, classified as immature teratoma, mature teratoma and teratoma with malignant transformation, and 2) tumors with extra embryonic tissue components, such as yolk sac tumor and choriocarcinoma. It is because of this classification that efforts have been made to understand the etiology of TGCT in order to influence the diagnosis and treatment of this neoplasia (22, 23 ).
GONOCYTE THEORY IN THE DEVELOPMENT OF THE GERM CELL NEOPLASIA IN SITU (GCNIS)
It is suggested that the origin of the GCNIS is during embryonic development and gonocytes (also called pre-spermatogonia) are responsible for this neoplasm. Gonocytes are cells that arise from the differentiation of PGCs that have migrated to the gonadal ridge and the allantois. Once established in this structure, they no longer migrate and differentiate into gonocytes (24). Gonocytes show morphological characteristics similar with atypical cells of GCNIS, also sharing the same profile protein expression of pluripotency and lifespan, as OCT3/4, now known as POU5F1, TFAP2C, c-KIT, PLAP and NANOG (14, (25) (26) (27) (28) . It is important to note that some of these proteins are used as biomarkers for diagnosing the GCNIS. An animal model that develops GCNIS has been proposed, exposing rabbits to 17-beta estradiol, considered DEs, which induces bilateral CO and GCNIS long term. © 1996-2017 During the development of neoplasia, it has been found that gonocytes persisted expressing pluripotency proteins like POU5F1, c-KIT and PLAP beyond its normal downregulation period (80 days old in the rabbit). This supports the theory of the origin of GCNIS from germ cells as they remain undifferentiated and pluripotent (29) . In healthy humans, gonocytes begin their differentiation into spermatogonia during the second to third trimester of pregnancy and concludes in the first months after birth (30, 31) . During this period, pluripotency proteins are regulated downward until their total disappearance, at about four months of age (28, 31, 32) . The lack of differentiated gonocytes in patients with CO, suggests that these cells are kept alive, undifferentiated and capable of pluripotency, which makes them susceptible to the development of GCNIS (33, 34) . Recently one study showed, by immunohistochemistry and RT-PCR, the presence of proteins POU5F1, c-KIT, AP2-gamma, Sall4 and PLAP in 5.4. percent (2/37) of patients with CO older than 12 months old, far beyond their normal differentiation period (16, 35, 36) , which proposed that GCNIS originates from fetal germ cells or gonocytes that reside latent in the testis, until they initiate proliferation after puberty by activation of hypothalamic-pituitarytesticular axis (37) . This causes an increased slow in testicular volume after puberty, leading to a delayed diagnosis around 25 to 35 years (38, 39) . There are reports where it is shown that in diseases such as gonadal dysgenesis, undifferentiated testicular tissue was positive to POU5F1 protein, c-KIT and PLAP during childhood gonadal tumor that develop in later stages (36) (Figure 1 ). In this sense, there have been studies in animal models documenting differentiation gonocytes, which is due to the contribution of factors produced by functional Sertoli cells, such as retinoic acid, stem cells factors, molecular cell adhesion, among others (40-43).
RISK FACTORS FOR THE DEVELOPMENT OF TGCT
Molecular, clinical and epidemiological studies have established evidence linking environmental and genetic factors in the development of TGCT (44, 45) . It is believed that development of TGCT comes from the GCNIS (12) (13) (14) (15) . These factors can influence the differentiation process avoiding PGC. Among the environmental factors, they have included EDs such as some pesticides and chemicals that can interfere in various stages of development male since gestational stage (46) . Furthermore, previous 
Environmental factors
From the 1950s, promising to improve quality of life standards, introduction of various chemicals structurally related to hormonal compounds was given, such as the EDs, including pesticide and some industrial waste products, were documented as compounds that affect the normal development in humans, after several studies. Epidemiological studies and animal models have demonstrated that exposure to EDs during organogenesis correlates with the increased incidence of malformations of the male genital tract, a decrease in sperm quality and testicular cancer development (47) . EDs have also shown that they alter the reproductive process in both men and women, modifying the neuroendocrine profile, aggressive behavior, metabolism, developing prostate and thyroid cancer (48) . The term of EDs arises in the Wingspread Conference in 1991, through an epidemiological study in European and North American population, and for the first time a relationship between exposure to these chemicals and decreased semen quality is proposed, in addition to finding a increased incidence of congenital malformations, such as cryptorchidism, hypospadias and an increased incidence of testicular and breast cancer. The action mechanism of EDs is proposed by the interruption in the synthesis, release, transport, metabolism, binding, action or elimination of endogenous hormones during embryonic development before, during or after organogenesis (Figure 2 ). Experiments have shown that hormone level variations can cause morphological and functional alterations in organisms. Fetal exposure to EDs occurs through the mother during pregnancy, to the infant through breastfeeding and during childhood by consuming formula wherein the containers have these compounds (47) . One of the first documented cases between the 1940s and 1970s was the use of diethylstilbestrol, which is a synthetic form of estrogen, indicated to prevent spontaneous abortions, premature births and other pregnancyrelated complications (48) . Years later it was found that this compound was not effective in preventing these problems, discovering in those prenatally exposed, the (49) (50) . Epidemiological data support the hypothesis that small increments in estrogen levels during fetal development increase the risk of developing hormone-dependent cancers such as the TGCT. Another ED studied is Bisphenol A (BPA), which is currently used in many products, such as baby bottles, water bottles, food containers, and for the production of epoxy resins among others. A study in USA, detected BPA in urine in 92 percent of the population tested. The use of BPA has already been legislated in some countries such as Canada, the European Union and United States of America, as well as some Latin American countries like Argentina, Colombia and Peru, but in Mexico is not still clear (51) . Animal models have reported that prenatal BPA exposure is associated with increased development of pre-cancerous lesions as GCNIS, which appear in adolescence. It has also been demonstrated in animal models exposed to BPA during breastfeed an increased risk of developing TGCT, compared to unexposed animals (52) . Several studies have found a risk association between exposure to EDs in agricultural areas and genital abnormalities in males. In fact, blood concentrations of organochlorines have been detected in mothers of patients with TGCT after several decades of diagnosis (53) . Moreover, some studies have found a correlation between high levels of phthalates in urine of pregnant women and their undervirilized offspring (54) . This interaction of disease and the environment, has been linked to epigenetic processes, like DNA and histone modifications, mainly in fetal adaptation to an environment in which the dose, the period of development and duration of this exposition are of great importance. In men, the exposure to EDs has been implicated in the development of testicular dysgenesis syndrome (TDS), which includes TGCT, CO, hypospadias and infertility, which suggests that fetal exposure to these compounds alter the functioning of the Leydig and Sertoli cells, modifying the development of germ cells (20, 55) .
Cryptorchidism as risk factor in the development of TGCT
The CO is the most common genitourinary birth defect in man and is important due to the complications in adulthood; including infertility and the TGCT risk (9, 56) . The CO has a variable prevalence from one to another country; Denmark has one of the highest incidences (9.0. percent) compared to Finland, which has one of the lowest incidences (2.4. percent) (9) . In Mexico, until now there are no epidemiological studies of this malformation. The CO can occur in one testicle (unilateral) or both (bilateral). The classification can be based on the location of the testicle: 1) abdominal, above the inguinal canal; 2) inguinal; and 3) ectopic, outside of the normal testicular descent path (10) . In embryonic stage, the testicle is located at the abdomen and then moves into the scrotum. In humans, the testicle in the abdominal position is suspended by two ligaments, one that connects the kidney to the gonad, called cranial suspensory ligament (LSC), and the other connecting the testis and epididymis to the floor of the scrotum called gubernaculum. Testicular descent in humans is presented in two phases called transabdominal and inguinoescrotal between week 8 to 17 and during the week 26 to 32 of gestation, respectively (57, 58) (Figure 3 ). This descent process occurs in order to provide testes a temperature of 1.5. to 4.0. degrees centigrade lower than the body temperature, allowing adequate spermatogenesis and optimal epididymal function (56, 58, 59) . Despite widespread knowledge of the testicular physiology, etiology of CO remains largely unknown. However, it is considered a multifactorial disease in which various mechanisms that regulate testicular descent have been proposed (59, 60) , possibly affected by endocrine, anatomical and genetic factors. It is suggested that environmental and genetic factors involved can intervene in early stages of embryonic development (61) . Based on its etiology, CO may occur as an isolated pathology; but it may also occur as part of any of the more than 250 genetic syndromes associated with this malformation (10, 60) . It has been documented that this malformation is the second risk factor for the development of testicular neoplasia. Patients with CO are 7 to 10 times more likely to develop TGCT (62) (63) (64) . Although this association is established, the mechanisms that lead to this disease are still unknown (12) (13) (14) (15) 61) . It has been documented that among individuals with unilateral CO, one of every four cases develops TGCT in the contralateral normally descended testicle (16, 17) . Also, it has been demostrated that the testicle with intraabdominal CO has an increased risk of developing malignancy, comparing with the others that stay at inguinal level. Indeed, patients with bilateral CO compared to unilateral cases have also increased risk (9, (18) (19) (20) . Based on these observations, it can be inferred that there are shared underlying genetic factors in the presence of CO and TGCT. Thus, CO can be the first symptom of a future alteration where TGCT and infertility can be manifestations of the same defect (20) . Different genes involved in the process of testicular descent, such as androgen receptor (AR), INSL3, GREAT and HOXA10 among others, as well as the prevalence of CO in different populations, is probably the result of ethnic differences (18, 19) . It is important to note, that certain genes interactions, specifically INSL3 and AR, have also been documented in both CO and TGCT. Several studies have shown that the production of INSL3 is sensitive to estrogenic or anti-androgenic compounds exposure, as EDs ( Figure 3 ), which clearly suggests that exposure to these compounds during pregnancy can result in cryptorchidism, a factor that predisposes to TGCT (65) . The impact of EDs in steroidogenesis could result in inhibition of the cholesterol supply and gene expression in the related pathway (66) . Another study with great importance in the etiology of CO reviewed the role of dioxin or Di (2-ethylhexyl) phthalate, (DEHP) which is also an ED, and demonstrated that it promotes transgenerational epigenetic inheritance of CO. This component was administered in the gonadal development period in pregnant female rats, which is a critical period, inducing the occurrence of CO in the offspring during pregnancy. The incidence of CO in the first generation (F1) was 30 percent, the F2 was 12.5. percent, while for the F3 and F4 generations was no development of CO. Results revealed many DNA sequences differentially methylated between F1 and F4. DEHP damages male reproductive function in rats affecting the expression of the DNA methyltransferase enzyme, which in turn leads to changes in methylation patterns of genomic imprinting, especially within CpG and promoter island regions, representing an important damage mechanism to the male reproductive system (Figure 3) . However, the authors attributed this phenomenon to a phosphorylation and negative regulation of MAPK cascade that could play an important role in epigenetic inheritance of the male reproductive system. This study represents one of the most important analyses about the influence between environment and development of CO, and the possible risk of developing TGCT by epigenetic mechanisms (67). However, the pathogenesis of CO remains uncertain, and it is unclear whether CO is a risk indicator for the development of TGCT, or is itself a precursor for malignancy. Therefore, it is difficult to speculate whether the prevalence of CO would be elevated among individuals with a predisposition to develop TGCT.
Family history in TGCT
Family history increases the risk of TGCT, however, this affects approximately 1 to 3 percent of patients who have one or more first-degree relatives affected by this neoplasia (62) . The relative risk is 7 to 10 times higher among siblings of patients with TGCT, while the relative risk of parents or children of affected individuals is 4 to 6 times, which is higher compared to other malignancies, emphasizing that not only the shared environmental factors among kindred, could be important in this kind of cancer, but also genetic susceptibility is an important factor. However, it is difficult to realize such studies because this cancer directly affects male reproduction (62-64), therefore it is complicated to study genetic predisposition, between one generation and the next, and identify precursor lesions in utero. However, histological differentiation produced at random, coupled with the influence from environmental exposure of EDs could explain the lack of a distinctive phenotype between cases of familial testicular germ cell tumor (FTGCT) and sporadic cases (1) . The phenomenon of genetic anticipation is one in which the hereditary disorders become more severe in future generations, as manifested by decreasing the Figure 3 . Action of endocrine disruptors (EDs) at different stages of testicular descent: A) During the transabdominal stage, the EDs can limit the production of INSL3 hormone; B) During the inguinoscrotal stage, the presence of can produce heritable changes in DNA methylation, which promotes MAPK deregulation, as a possible epigenetic mechanism of cryptorchidism, which is considered a risk factor of TGCT. © 1996-2017 age at onset of disease and increased clinical severity of the disease. This pattern has been described in affected families with parents and children with TGCT, noting a significant decrease in the age of diagnosis of TGCT in the younger generation, although it is possible that the observed difference is a secondary device of several statistical bias (68) (69) (70) . Another possible explanation of what resembles genetic anticipation is that younger men with more aggressive disease may have decreased fertility after treatment, while the grandparents and parents have the disease in older age and a less aggressive histological type, so they may be more likely to reproduce before being diagnosed with cancer, and more likely to remain fertile after treatment. Most young parents have presented nsTGCT at a time when the chances of healing were more complicated by monetary conditions compared to older patients with sTGCT who had better financial means, plus the fact that the treatment was often gonadotoxic and bound to fertility (i.e., "the bias fertility"). With the introduction of cisplatin and more effective treatment regimens, younger patients with TGCT are more likely to survive and remain fertile after treatment. The increased disease severity is an important aspect of anticipation; unfortunately, it does not have enough epidemiological information so far (1) . In 2000, the International Testicular Cancer Linkage Consortium (ITCLC) reported the association between a locus on Xq27 chromosome and 134 families with confirmed diagnosis of TGCT from the NIH Clinical Center and other participating countries (HLOD equal to 2, 01 and 4.7. in familial cases) (71) . Eighty-eight percent of the families in this study had only two affected males, while 53 families (12 percent) had 3 or more cases, with 5 being the highest number of affected family members. It is important to highlight that of the families linked to this locus, 73 percent had a history with cryptorchidism, while 26 percent did not (statistical significance equal to 0.0.3), providing evidence of the possible association of locus Xq27 and TGCT and also with CO, which is a major risk factor for the development of this neoplasm, so is important to find risk variants for both diseases (71, 72) . Later work decided to replicate the 2000 study of 134 families by the same consortium in order to expand and corroborate the association of the Xq27 locus in patients with FTGCT, however, the new linkage analysis in 237 families could not corroborate previous findings, additionally this study failed to identify additional candidate genes for new susceptibility loci with high penetrance (73) . Due to the complexity of the etiology of FTGCT and the results obtained, a new hypothesis of genetic susceptibility for this tumor has changed the approach in the investigation of this neoplasm, including the combined effect of multiple low penetrance risk alleles are part of the genetic load of this disease. The collaboration of ITCLC found a high impact prevalence of the microdeletion gr/gr in the genomic region AZFc analyzed because it is the most common genetic cause of infertility and sterility, and a known risk factor for development the TGCT. This deletion was present in 13/431 (3.0. percent) of the FTGCT cases, 28/1376 (2.0. percent) with sporadic TGCT, and 33/2599 (1.3. percent) men without TGCT, obtaining an odds ratio of 3.2. and 2.1., respectively (74) . The authors concluded that this Y chromosome microdeletion is a low penetrance variant in susceptibility. It should be noted that there are other genes reported with inconclusive results (DND1,  ERS1, ERS2, RLN, LHCCGR, DICER1, AKT1, PTEN,  PDE11A) . However, it is noteworthy that the three genes (ERS1/ERS2, RLN, LHCCGR) involved for the first time by Genome-wide association studies (GWAS) were part of a central signaling pathway to the biology of normal germ cells (72) [75] [76] [77] [78] [79] [80] . Besides, c-KIT/KITLG is present in other important biological pathways, including fertility, spermatogenesis, testicular differentiation, doublestranded DNA repair, chromosome segregation, chromatin remodeling, and maintenance of telomeres, apoptosis, c-AMP signaling pathway and sexual determination. Supporting the hypothesis of genetic susceptibility, all these risk alleles represent approximately 15 to 22 percent risk in the FTGCT (79, 81) . Attempts of association between risk SNPs and other risk factors such as FTGCT, cryptorchidism, inguinal hernia, age at diagnosis, bilateral TGCT, and histology of the tumor had not any success (73) . Some of the GWAS studies have agreed on various genes such as KITLG, BAK1, DMRT1, and TERT (62), in both FTGCT and sporadic TGCT without distinction, corroborating the genomic similarities (72) . Both TGCT and prostate cancer (CaP) could be plausibly seen as hormonal related tumors and as such, several common low risk susceptibility alleles may resemble the pattern of the associations observed in other endocrine disorders, such as diabetes mellitus type 2, which has more than 70 modifying risk variants described (82) ( Table 1 ).
MOLECULAR ASPECTS ASSOCIATED WITH TESTICULAR GERM CELL TUMORS

Single nucleotide polymorphisms (SNPs) and mutations related to the development of TGCT
In recent years, genetic studies have been performed based on the search for biomarkers for TGCT, with the purpose of revolutionizing the field of diagnosis and treatment, documenting in various populations genetic factors involved with TGCT. It is important to note that so far no strong differences in the patterns of alterations or set of single nucleotide polymorphisms (SNPs) and expression patterns between sporadic and familial cases of TGCT have been found (83) . They have identified some loci of susceptibility in several GWAS studies, such as chromosome 12 associated to KITLG and ATF7IP genes, and specifically the ligandreceptor c-KIT/KITLG pathway has been implicated in the development of PGC. c-KIT is a proto-oncogene which plays an important role in the physiological regulation of cell proliferation and differentiation, so that changes in conformation or expression may promote transformation to malignancy and tumor progression; c-KIT is the cellular counterpart of the oncogene v-kit Hardy-Zuckerman 4 feline viral sarcoma. In humans, the c-KIT gene is located on chromosome region 4q11-q12 with a length of 82.7.87 bp, encoding a tyrosine kinase activity receptor, involved in hematopoiesis, melanogenesis and spermatogenesis (75, 84) . This protein functions as a transduction signal system essential for the survival, migration and differentiation of early germ cells. It is strongly expressed in gonocytes in fetal and pediatric stages. Many alterations in this gene, result in the activation of c-KIT in an uncontrolled manner (84) . To date, there have been several points likely to have gene mutations, in exons 9, 11, 13 and 17; in the latter, it has been characterized the D816H and D816V alterations associated with development of neoplasia, including performing studies of genotypephenotype correlation determining that these variants are frequently present in patients with bilateral TGCT and not in patients with the unilateral phenotype. KITLG, also known as stem cell factor (SCF), is the other component of this pathway, as described as the ligand of c-KIT. This gene is located on chromosome region 12q21.3.2, which is indispensable to carry out the dimerization and auto phosphorylation of c-KIT, activating the signaling pathway c-KIT-KITLG. Kanetsky et al., document variations in the sequence of KITLG (rs995030, rs4474514 and rs3782179) giving predisposition to develop TGCT, suggesting that KITLG plays a decisive role in pigmentation, also postulating that these variations could give an explanation, in part, why the incidence of TGCT is higher in whites than in African-Americans, besides being associated with infertility in males (83) . Two of the genes associated via c-KIT/KITLG are SPRY4 and BAK1 genes. SPRY4 is located on chromosome 5, it has been described as an inhibitor of protein kinase pathway linked to TGCT. On the other side BAK1 located on chromosome 6, has been associated with neoplasia because the same signaling pathway suppresses it, additionally acting as a promoter of apoptosis in the germ cells by binding the repressor BCL2. TERT-CLPTM1 located on (72) . Another important factor of TGCT development is sex steroids, which play an important role in the risk and progression of malignancy. The classical genomic androgen action is mediated by the androgen receptor (AR); its deficiency leads to an increased number of gonocytes during the fetal period. GCNIS cells express AR unlike normal stem cells in the adult male that not express it. The protein functions as a signal transduction system on nuclear level, regulating gene transcription, which modifies cellular functions. This dimeric receptor is activated by androgens and interacts with the aminoterminal structure or transcriptional activation domain and after activation zinc fingers joins are set in the DNA binding domain, and subsequently the androgen binds by a hinge region to the ligand binding domain, and initiates transcription of genes that regulate androgen response. The AR gene is located in the Xq11q12 region where SNPs are associated with the development of TGCT (P390S, A279T, rs12014709) in addition to the repeated glutamine and glycine tracts (85) (86) (87) . One of the most widely SNPs characterized in the AR gene in humans are these tracts located in the trans-activation domain, which is encoded by a polymorphic CAG and GGC repeats respectively, which is inversely correlated to the trans-activation in vitro, such that less trans-activation is expected for men with higher number of repeats. Thus, individuals that have been detected with a mutated copy of AR, which has long repeated low transactivation and high levels of circulating androgens. It is postulated that the presence of these polymorphic sequences may be involved in increasing the risk of TGCT, since these variants alter receptor function that leads to insensitivity of androgens, causing high concentrations of testosterone and estrogen in circulation. Dao et al. conducted a study and found that short repeats are strongly associated with TGCT patients, specifically seminoma (88). Furthermore, Västermark et al. showed that rs12014709 variant is associated with an increased risk of neoplasia in spite of being located in the noncoding region of this gene (87) . DMRT1 is a transcription factor, a member of the DNA binding gene family, one of the most important genes of the DMRT group, distinguished to have a DM domain, which is a highly conserved zinc finger across species, with strong implications in testicular development in vertebrates. This is expressed as a pluripotency gene in TGCT, like other genes as POU5F1 and NANOG, whereas in normal adult germ cells these genes are not expressed, so that DMRT1 expressed in the gonad during maturation of Sertoli cells, participates in the regulation of differentiation there of, in gametogenesis and sexual determination in certain vertebrates (89, 90) . Recently, studies with animal models have shown that DMRT1 participates in modulating, signaling and tumor pluripotency. DMRT1 is located on chromosome region 9q24.3. and is also one of the genes involved in tumor development, with variants (rs7040024 and rs755383) in this gene having a strong relationship with susceptibility to TGCT (89), besides being associated with gonadoblastoma when this gene is deleted. It is proposed that the epistasis between risk variants and the development of TGCT is characteristic in this kind of tumor, and so far has not been able to detect rare mutations with high penetrance. One of the studies conducted in recent years analyzed gonadal dysgenesia syndrome which consists of TGCT, CO, hypospadias and infertility, where identifying new genes involved in the development of this syndrome (TGFBR3 and BMP7) belong to the TGFB signaling pathway using SNPs microarray. This also corroborates what has been described for c-KIT/KITLG pathway, highlighting the fact gonadal dysgenesis is a real syndrome, even when questioning the relationship between the same pathologies in isolation for the development of TGCT, which is predominantly dependent on the environment, proposing that the pathogenesis of this tumor has a relatively weak genetic component due to the current lifestyle of man. This study also highlights the close relationship found between TGCT and CO by which TGFBR3 gene has not been associated to date. This encoding TGFBR3 protein is expressed in most endocrine tissues, including the testis; this in turn has been identified in Sertoli and Leydig, both normal cells and in the GCNIS (91).
Epigenetic mechanisms in the development of TGCT
One of the most relevant fields today, is the study of heritable changes in gene function that occur without a change in DNA sequence, known as epigenetic changes, which are of great importance in the research of the development of several tumors. Different epigenetic mechanisms modulate gene expression, activating or repressing, and can work together or in an isolated manner, such as DNA methylation, histone modification and silencing RNA genes associated by the action of miRNAs(92) (Figure 4 ).
DNA methylation
Is the most studied epigenetic process and it has been recognized as an important mechanism for TGCT progression (93) . In addition, patterns of DNA methylation appear to correlate with histological features of different types of TGCT, identifying hypomethylation in seminoma, GCNIS and gonadoblastoma, while hypermetilation in teratoma, yolk sac tumor, and choriocarcinoma; finally, embryonal carcinoma cases showed an intermediate methylation pattern. Furthermore, the expression pattern of DNMT3b has been widely studied and demonstrated that it could be used as a predictive marker for relapse of sTGCT in stage I, while overexpressed DNMT3l is found in nsTGCT (94) . Two of the most important findings are identifying methylation patterns in NANOG and POU5F1 genes that aim to regulate pluripotency in fetal germ cell tumors and in undifferentiated germ cells, such as the hypomethylation of DNA in the promoter of NANOG gene in spermatogonia and hypermethylation in the sperm, that could reflect that cells need this selective mechanism to delete their pluripotent character in order to prevent malignant transformation, in addition identifying methylation CpG islands in the promoter of NANOG gene in germ cell tumors. Additionally, the study showed DNA hypomethylation in POU5F1 gene, in both sTGCT and embryonal carcinoma (95) ( Table 2) .
Normally in the male germline, there are various epigenetic modifications, until spermatogenesis is fully functional. In fact, it has been shown that through the different stages of spermatogenesis, from the gonocytes to sperm, germ cells experience dynamic epigenetic modifications, highlighting changes in the expression patterns of various enzymes such as DNA methyltransferases (DNMTs), which is mainly expressed in spermatogonia, while the HMTs is expressed mainly in spermatocytes (96) . As described throughout this review, environmental factors represent a fundamental factor in the development of TGCT. There are several studies showing that the presence of EDs may impact the epigenome, interestingly, has been shown in the last decade that these effects could also have an impact on subsequent generations by modifying DNA methylation in the germline (97) . Such effect was demonstrated for the first time with exposure to vinclozolin, a compound with anti-androgenic activity, identifying differential expression of genes such as DNMT, which is responsible for histone modifications (98) . These changes in epigenetic programming through the EDs are of particular interest because it is suspected that they are responsible for increasing the frequency of pathologies related to the TDS. Indeed, it appears that epigenetic tumor cells show a similar pattern to undifferentiated spermatogonial stem cells, GCNIS have a fetal-like chromatin structure (99) , and also the precursor of TGCT has already been identified in testis of embryos. Another key mechanism associated with the development of TGCT is the modification on an epigenetic level in aberrant DNA methylation. Several studies have focused on trying to elucidate the epigenetic hallmark of this neoplasia. It has been identified in testicular tissues that methylation on promoters inactivate tumor suppressor genes whereas hypomethylation cases have been reported on a somatic level (100). Since TGCT have not been able to identify rare disorders with high penetrance for development, a trend has emerged that suggests that this neoplasia may be due to aberrant DNA methylation, this being an alternative pathway that could explain the etiology of this disease. In 2010 the global methylation of LINE-1 was assessed by pyrosequencing in 446 families of 101 multple-case testicular cancer familiar and found a strong positive association between mother-daughters (r= 0.4.8; p= <0.0.01) and father-daughter pairs (r= 0.3.1; p= 0.0.2) suggesting gender-specific inheritance of methylation. When they analyzed cancer status, they observed a strong correlation in LINE-1 methylation leves only among affected father-affected song pairs (r= 0.4.9; p= 0.0.3). These data suggest that the heritability of the methylation pattern of LINE-1 could be gender specific, i.e. the epigenetic inheritance may be associated with risk of developing TGCT (101) . Another follow-up study of the same families investigated the promoter methylation of some candidate genes (KITLG, SPRY4, BAK1, PDE11A, DND1) that might be associated with a risk in the FTGCT. Comparing the affected family members with those unaffected ones, increasing promoter methylation in PDE11A, SPRY4, and BAK1 and decreasing promoter methylation in KITLG. were observed. This data suggests that susceptibility in patients with FTGCT may be associated with promoter methylation in genes risk modifiers (102) , findings that deserve further follow-up in larger study populations. Other studies focused on sporadic TGCT have searched for methylation profiles in the complete genome, identifying deregulating APOLD1, RGAG1 and PCDH10 genes by hypermethylation of promoter regions. (103) These studies show that epigenetic reprogramming could be important in the pathogenesis of TGCT, providing a possible interesting relationship between environmental risk factors, particularly with respect to hormonal mechanisms, susceptibility to disease, and development risk of TGCT (104) . On the other hand, epigenetic studies of sporadic cases of TGCT have identified that DNA methylation is critical for the development of germ cells, and these enzymatic modifications depend on DNMTs. Specifically during germ cell development in the prenatal stage, establishing de novo methylation by expression profile consists initially of DNMT3a and DNMT3l, while DNMT1 and DNMT3b occur after birth in the male. Therefore, these isoforms that increase DNMTs. must be involved in the maintenance of methylation patterns in spermatogonial proliferation (105) . The primary role of these epigenetic alterations has been demonstrated in models of carcinogenesis; in fact, it has been shown that DNA methylation is associated with repressed expression of tumor suppressor genes.
Histone methylation
These modifications are carried out in spermatogenesis by several members of the histone methyltranferases family (HMTs), which may mediate the dimethylation or trimethylation in histone 3 (H3) of lysine 9. The G9a, is a HMTase candidate for methylation of H3-K9 in a non-heterochromatic loci. Mice lacking G9a are sterile, which produces apoptosis in germ cells during the pachytene stage (109) ( Table 2 ). In addition, it was shown that G9a was a target of retinoid signaling via a key regulator of germ cell differentiation. It has been suggested that dimethylation of arginine 3, histones H2A and H4 may be a mechanism by which sTGCT and GCNIS maintain their undifferentiated state; while the loss of these histone modifications could be involved in somatic differentiation observed in nsTGCT (107) . Added to this, methylation of H3-K4 and K9 histones could be associated with abnormal expression of LSD1/KDM1 in nsTGCT, which suggest that is a histone demethylase that suppress gene expression by converting to monomethylated to dimethylated H3K4 Interestingly, the level of protein LSD1 is very high in cancer cells and tissues, expressing sTGCT POU5F1 (108).
Acetylation of histone
Acetylation of histones also leads to gene repression and is performed by specific enzymes called histone deacetylases (HDCA). The hyperacetilation of histone H4 during spermatogenesis is one of the 
Participation of microRNAs (miRNAs) in the development of TGCT
Currently one of the mechanisms studied extensively in the origin of TGCT and timely diagnosis is leaded by microRNAs (miRNAs/miRs), which are a class of small non-coding single RNA's strand. The miRNAs are synthesized and processed in the nucleus, then are exported to the cytoplasm where they bind to complementary mRNA sequences, altering their expression through a silencer complex or inducer RNA (RISC, RNA-induced silencing complex). The process of miRNAs biogenesis starts with primary transcripts or pri-miRNA containing a cap 5' and a tail in 3' of polyadenine (poly-A) that are processed in the cell nucleus in short fragments of 70 nucleotides of length in a stem-loop form, which are known as pre-miRNA. This processing is performed by a protein complex called microprocessor that comprises the nuclease Drosha and the RNA double helix binding protein, Pasha. Subsequently these pre-miRNAs mature in miRNA, having a length of 19 to 23 nucleotides in the cytoplasm by interaction of Dicer endonuclease, initiating the RISC complex formation (RNA-induced silencing complex) then obtaining double strand miRNAs, which finally will join a specific or non-specific mRNA. It should be noted that non-classical form may have the alternative biogenesis of miRNA stem-loops derived from intronic sequences; in this case are processed by Dicer but not Drosha. Both, the sense strand and the antisense strand of DNA can function as a template to produce miRNAs. The miRNAs negatively control the expression of genes at post-transcriptional level by binding to the 3'UTR region of their target mRNA, and induce their degradation or inhibit translation. By function, miRNAs have been described as fundamental and specific regulators of several cellular biological processes (113-114) ( Figure 5 ).
It is estimated that more than 50% of all cellular transcripts are targets of miRNAs, and each miRNA can potentially regulate hundreds of targets. Some miRNAs show a restricted distribution in tissues and can also be located through various biological fluids (115, 116) . It has been shown that there are changes in the expression profile of miRNAs that may correlate with various pathophysiological conditions, including certain types of malignant tumors. Thus, it has recently been discovered that deregulation of expression of various miRNAs is strongly associated with carcinogenesis as it directly acts over the expression of oncogenes and tumor suppressor genes, thus miRNAs are key in regulating the hallmarks of cancer such as cell growth and survival, apoptosis, angiogenesis and metastasis (117) . In the TGCT one of the main lines of research related to miRNAs focuses on determining its function as diagnostic markers, prognostic risk and response to treatment, and the classification type of TGCT. In this sense it has been reported that miR-302-367 and mir-371-373 clusters are expressed in embryonic stem cells as well as in patients with seminoma and not others histotypes. Furthermore, these clusters are able to differentiate tumor tissue from non-tumor tissue (118) . Other reports show that miR-17-5p and miR-154 are suppressed in teratomas, while the miR-301 is over-expressed in teratomas, seminomas spermatocytic and yolk sac tumors. Recently, Dieckmann et al. have shown increased levels of miR-371, miR-373, miR-376 and miR-302 in patients with TGCT (119, 120) . Interestingly, the expression of these miRNAs were higher in patients who developed metastases but surprisingly the levels of miRNAs decreased after orchiectomy, reaching expression levels similar to healthy controls. The authors also reported a significant decrease in expression of this group of miRNAs in patients with metastases treated with chemotherapy. These analyzes had a sensitivity of 98 percent from the 60 percent shown by alphafetoprotein (AFP), human chorionic gonadotrophin (hCG) and lactate dehydrogenase (LDH) (119, 120) . Other studies have shown that miR-302a increases the sensitivity to cisplatin in cell lines derived from TGCT by increasing levels of apoptosis in vitro (121) . Serum levels of miR-367-3p, 371a-3p, 372-3p and 373-3p increase significantly in patients with TGCT in locally advanced and metastatic stage compared with healthy individuals and patients with non-malignant testicular diseases. In particular miR-371a-3p allowed the identification of patients with TGCT with a sensitivity of 84.7. percent and a specificity of 99 percent surpassing the AFP and hCG (122) . In the carcinogenic process of TGCT, miR-372 and miR-373 have been described as oncogenic regulators to modulate the proliferation and apoptosis. The oncogenic activity of miR-372 and miR-373 is based on cooperation with mutated RAS, at least in part by direct regulation of LATS2 (tumor suppressor kinase 2). This inhibition interferes with cell arrest p53-p21 initiated by increasing CDK-cell proliferation in the testis. Interestingly, it was observed that the miR-302 to 367 is transcriptionally activated by POU5F1, SOX2 and NANOG, which are regulators of pluripotency in embryonic pluripotent cells (123) . In addition, an inverse association between resistance to treatment with cisplatin and expression of miR106b and POU5F1 was demonstrated. This seems to be modulated by over-expression of p21 at a cytoplasmic level, suggesting the way of modulation POU5F1/miR-106b/p21 as a new alternative in the treatment of chemoresistant TGCT (124) . On the other hand miRNA-21, miRNA-221 and miRNA-222 are overexpressed in seminoma compared to nonseminoma testicular tissue. The miR-21 negatively regulates ETV5, a transcription factor that plays an important role in stem cell renewal at the spermatogonia level (125) . The miR-221 and miR-222 regulate the expression of PTEN, which regulates AKT and this event is related to radiosensitivity in sTGCT (126) ; miR-1297 decreases the expression of PTEN to promote proliferation of cells derived from TGCTs (127) . Recently it was reported that Meg3, a long non-coding RNA, counteracts the action of miR-1297 on PTEN, allowing the tumor suppressor function of PTEN and its regulatory action on the PI3K/AKT in TGCT (128, 129) . All of this data indicate that miRNAs can be key drivers of the carcinogenic process in TCGT, emphasizing that molecules are expressed differentially in tissues of various subtypes of TGCTs, and serum of patients with TGCTs representing a potential tool diagnostic and therapeutic that should be explored in clinical practice (Table 3; Figure 6 ).
Proteomics of TGCT
Testicular environment is considered a particular microenvironment, where spermatogenesis is carried out and is important to note that there are similarities between spermatogenesis and tumorigenesis at testicular level in humans, so it is of great importance to study these two biological processes. Currently one of the problems in identifying protein markers is the low number of associated proteins to TGCT, due to conventional technological limitations necessary fot the characterization of these markers. However, in 2013 Liu et al. conducted a massive search for tumor markers by proteomic techniques such as 2D HPLC-MS/MS, which were validated by immunohistochemistry with previous data from an online Human Testis Proteome Database (HTPD) and additionally this information was supported by the use of a GWAS study, using associated SNPs where some differential expression of these protein markers were found. This study characterized six new proteins (DMTR1, PIWIL1, TMPRSS12, TPPP2, PRSS55 and HEMGN) and SNPs in the respective genes, involved in TGCT; the last four proteins still have unknown functions in testis, although they are proposed to play important roles in spermatogenesis and tumorigenesis (130) . The Mab-3 doublesex-and Related Transcription Factor 1 (DMTR1) together with the allelic variant rs408200 in this gene have been linked to cases of prostate cancer; this protein is a regulator of mitotic proliferation of germ cells (130, 131) , which contains a zinc finger structural motif © 1996-2017 that could contribute to cell proliferation of cancer (130, 132) . The second protein is Piwi-Like RNAMediated Gene silencing 1 (PIWIL1) which together with the allelic variant rs10773777 was also found in prostate cancer cases; this protein is a member of the evolutionarily conserved PIWI subfamily, and could play a role in RNA silencing during translational regulation. Previously, PIWIL1 was also detected in human sarcomas and pancreatic cancers, but was not seen as a particular protein in TGCT. It has been established that PIWIL1 has a role in tumorigenesis, increasing overall DNA methylation (130, (133) (134) . The third of these proteins is Transmembrane (C-Terminal) Protease, Serine 12 (TMPRSS12) that had only been associated to colorectal cancer with the variant rs11169552; this protein is expressed in spermatids and spermatocytes (130, 135) . The Tubulin Polymerization-Promoting Protein Family Member 2 (TPPP2) and its variant rs1952524 (present in tubulin unions), was associated with liver cancer (130, 136) . Another protein is the Protease Serine 55 (PRSS55) along with the variant rs4404875, is associated with cases of prostate and ovarian cancer, and is mainly expressed in Leydig and Sertoli cells in testis and proposes that its primary role is to regulate fertility in males (130, 137) . Finally Hemogein (HEMGN) and its 5 variants rs10984103, rs1443343, rs7024345, rs907580 and rs925487 have been associated with thyroid cancer; this protein regulates proliferation and differentiation in hematopoietic cells. Its overexpression blocks megakaryocyte differentiation induced by TPA K562 cell line as well as preventing apoptosis through the activation of nuclear factor-kappa B (NFkB) (130, 138) . In this study it was found that the total of 300 genes encoding proteins expressed in human testis, play an important role in spermatogenesis and fertilization. Only 22.7. percent (68 of 300) were genes encoding related TGCT proteins, of which only 66 proteins were evaluated. It is important to note that only INSL3 was not detected in germ cells, while the remaining 65 were detected in germ cells. Interestingly only 20 of the 65 identified were associated with TGCT, suggesting the existence of other candidate proteins, which have not been identified due to less sensitive methodologies in the area of proteomics. These six proteins mentioned, are important drug targets for personalized therapy in this neoplasm in the future candidates (130) ( Table 4 ).
CONCLUSIONS
Comprehension of the pathophysiology of TGCT has to be approached in a multidisciplinary way, although we understand more of this neoplasm, much remains to be done regarding the research, focused on the carcinogenic process, both in the search for diagnostic markers in risk populations, and identification of prognostic markers, and response to treatment. One of the key pieces that will further help to understand the pathophysiology of this cancer is the study of the interactions between the different gene variants and the impact they have on the development of TGCT, without leaving aside the important role the environment plays in this condition, as well as the longterm effects that may trigger exposure to compounds such as EDs and their potential impact at the cellular level and epigenetics. Another line of research of great importance is to find the relationship between the development of TGCT and risk factors, such as CO, so the approach to this problem necessarily have to be done by massive analysis technologies to give ways to predict the development of neoplasia; making it clear that there is much to do about it, given the complexity of this disease. 
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